发明名称 |
COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO |
摘要 |
Disclosed are medicaments, pharmaceutical compositions, pharmaceutical kits, and methods based on combinations comprising, separately or together: (a) a CYP3A4 inhibitor; and (b) a HCV protease inhibitor; for concurrent or consecutive administration in treating a human subject infected with HCV.
|
申请公布号 |
CA2647158(C) |
申请公布日期 |
2012.07.31 |
申请号 |
CA20072647158 |
申请日期 |
2007.03.19 |
申请人 |
SCHERING CORPORATION |
发明人 |
RALSTON, ROBERT O., II;STRIZKI, JULIE M.;VLACH, JAROMIR;GUPTA, SAMIR K.;O'MARA, EDWARD M.;GHOSAL, ANIMA;TREITEL, MICHELLE A.;MCLEOD, JAMES F.;WHITE, RONALD E. |
分类号 |
A61K31/16;A61K31/192;A61K31/196;A61K31/343;A61K31/395;A61K31/40;A61K31/403;A61K31/427;A61K31/454;A61K31/496;A61K31/4965;A61K38/06;A61K38/07;A61K45/06;A61P31/12 |
主分类号 |
A61K31/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|